Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2124396 | European Journal of Cancer | 2009 | 7 Pages |
Abstract
The optimal chemotherapy utilisation rate can serve as an evidence-based benchmark in the planning and evaluation of chemotherapy services. Chemotherapy may be under-utilised in the initial management of patients presenting with metastatic colon cancer.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Susannah Jacob, Weng Ng, Ray Asghari, Geoff P. Delaney, Michael B. Barton,